Mersana Therapeutics Inc Revenue per Employee (MRSN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Mersana Therapeutics inc   (NASDAQ: MRSN)
 

Mersana Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Mersana Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 325,294, but the productivity of Mersana Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 288 other companies have achieved higher revenue per employee. While Mersana Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1891 to 2116. Mersana Therapeutics Inc has 102 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRSN Revenue per Employee (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Revenue Change -12.61 % 33.28 % -70.21 % 52.89 % 63.65 %
Sales per Employee (TTM) $ 325,294 340,873 333,392 397,029 341,539
MRSN's Total Ranking # 2116 # 1891 # 1852 # 1074 # 908
Seq. Revenue Change 260.24 % 10.97 % -83.17 % 29.87 % 449.41 %

MRSN Company Profile >> Back to MRSN Efficiency Comparisons >> Compare MRSN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 137
Healthcare Sector # 289
Overall Market # 2116

Revenue per Employee Statistics
High Average Low
$ 400,412 $ 189,509 $ -255
(Sep 30 2023)   (Sep 30 2020)



Financial Statements
Mersana Therapeutics Inc 's Revenue MRQ $ 11 Millions Visit MRSN's Income Statement
Mersana Therapeutics Inc 's Revenues TTM $ 33 Millions Visit MRSN's aggregate revenue growth
What are MRSN's Sales? Visit MRSN's Sales by Segment




Other Ratios
Mersana Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MRSN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MRSN's Competitors
Revenue per Employee for MRSN's Suppliers
Revenue per Employee for MRSN's Customers

You may also want to know
MRSN's Sales Growth Rates MRSN's Pe Price to earnings ratio MRSN's Receivables Turnover Ratio MRSN's Stock Quote
MRSN's Net Income Growth Rates MRSN's Ps Price to Sales ratio MRSN's Sales per Employee MRSN's Asset Turnover Ratio
MRSN's Net Margin MRSN's Pb Price to Book ratio MRSN's Financial Strength Ratios MRSN's Dividend Payout Ratio
Date modified: 2026-08-29T17:41:57+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2025Number of Employees Sep 30 2025
Coherus Oncology inc   568,489.80 $ 83.568  Million 147 
Intuitive Surgical Inc   564,608.42 $ 9,610.200  Million 17,021 
Sensus Healthcare Inc   561,000.00 $ 33.660  Million 60 
Instil Bio Inc   558,823.53 $ 9.500  Million 17 
Accuray Incorporated  556,299.13 $ 450.046  Million 809 
Organogenesis Holdings Inc   544,751.76 $ 465.218  Million 854 
Enanta Pharmaceuticals Inc  544,366.67 $ 65.324  Million 120 
10x Genomics Inc   542,853.99 $ 639.482  Million 1,178 
Merus N v   539,104.76 $ 56.606  Million 105 
Phibro Animal Health Corporation  537,516.31 $ 1,400.230  Million 2,605 
Koru Medical Systems Inc   535,214.21 $ 39.071  Million 73 
Editas Medicine Inc   533,149.43 $ 46.384  Million 87 
Iridex Corp  530,494.62 $ 49.336  Million 93 
Mannkind Corporation  530,045.61 $ 313.787  Million 592 
Perrigo Company Plc  528,518.52 $ 4,281.000  Million 8,100 
Opus Genetics Inc   522,607.14 $ 14.633  Million 28 
Henry Schein Inc   517,520.00 $ 12,938.000  Million 25,000 
Jin Medical International Ltd  517,181.85 $ 20.687  Million 40 
Si bone inc   510,970.74 $ 192.125  Million 376 
Orthofix Medical Inc   509,978.82 $ 818.516  Million 1,605 
Assembly Biosciences Inc   509,465.75 $ 37.191  Million 73 
Zymeworks Inc   509,397.73 $ 134.481  Million 264 
Neuroone Medical Technologies Corp  505,427.33 $ 9.098  Million 18 
Delcath Systems Inc   503,756.41 $ 78.586  Million 156 
Nexgel Inc   498,894.74 $ 9.479  Million 19 
Coya Therapeutics Inc   498,463.25 $ 3.988  Million 8 
Bionexus Gene Lab Corp   498,158.21 $ 9.465  Million 19 
Teva Pharmaceutical Industries Limited  494,197.35 $ 16,778.000  Million 33,950 
Bausch Health Companies Inc   494,039.41 $ 10,029.000  Million 20,300 
Skinhealth Systems Inc   492,123.98 $ 301.672  Million 613 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.